Skip to main content
Loading ResearchHub…
Cited by — BTK/BCL2 dual targeting enhances apoptosis in marginal zone lymphoma: preclinical activity of tacabrutideg (BGB-16673) and sonrotoclax | ResearchHub - ResearchHub